Dual inhibition of BRAF and MEK increases expression of sodium iodide symporter in patient-derived papillary thyroid cancer cells in vitro

The majority of papillary thyroid cancers are driven by acquired mutations typically in the BRAF or RAS genes that aberrantly activate the mitogen-activated protein kinase pathway. This process leads to malignant transformation, dedifferentiation, and a decrease in the expression of the sodium-iodid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgery 2020-01, Vol.167 (1), p.56-63
Hauptverfasser: Ullmann, Timothy M., Liang, Heng, Moore, Maureen D., Al-Jamed, Isra, Gray, Katherine D., Limberg, Jessica, Stefanova, Dessislava, Buicko, Jessica L., Finnerty, Brendan, Beninato, Toni, Zarnegar, Rasa, Min, Irene M., Fahey, Thomas J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!